Access to anti-retroviral drugs, male in Iceland
Iceland: Access to anti-retroviral drugs, male was 89.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, male in Iceland, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Iceland is 89.0%, measured in 2024.
Compared with earlier readings it is down 2.2% on the previous year and up 36.9% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Iceland peaked at 91.0% in 2023 and was at its lowest, 27.0%, in 2000.
Iceland ranks 17th of 141 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, male in Iceland, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 27.0% | — |
| 2001 | 33.0% | +22.2% |
| 2002 | 38.0% | +15.2% |
| 2003 | 43.0% | +13.2% |
| 2004 | 46.0% | +7.0% |
| 2005 | 49.0% | +6.5% |
| 2006 | 51.0% | +4.1% |
| 2007 | 52.0% | +2.0% |
| 2008 | 55.0% | +5.8% |
| 2009 | 59.0% | +7.3% |
| 2010 | 61.0% | +3.4% |
| 2011 | 63.0% | +3.3% |
| 2012 | 64.0% | +1.6% |
| 2013 | 65.0% | +1.6% |
| 2014 | 65.0% | +0.0% |
| 2015 | 65.0% | +0.0% |
| 2016 | 66.0% | +1.5% |
| 2017 | 76.0% | +15.2% |
| 2018 | 79.0% | +3.9% |
| 2019 | 82.0% | +3.8% |
| 2020 | 85.0% | +3.7% |
| 2021 | 84.0% | -1.2% |
| 2022 | 83.0% | -1.2% |
| 2023 | 91.0% | +9.6% |
| 2024 | 89.0% | -2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.3% | 27.0% | 59.0% | 10 |
| 2010s | 68.6% | 61.0% | 82.0% | 10 |
| 2020s | 86.4% | 83.0% | 91.0% | 5 |
Countries ranked near Iceland
More gender data for Iceland
- Child population (UN estimates and projections) 69.14 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.228 % change on previous year (2030)
- Population 345.21 (2030)
- Working-age population (UN estimates and projections) 345.21 (2030)
- Population (UN estimates and projections), annual growth rate 0.7736 % change on previous year (2030)
- Age population, age 00, female, interpolated 2,155 (2025)
- Age population, age 00, male, interpolated 2,290 (2025)
- Age population, age 01, female, interpolated 2,184 (2025)
- Age population, age 01, male, interpolated 2,324 (2025)
- Age population, age 02, female, interpolated 2,211 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Iceland?
- Access to anti-retroviral drugs, male in Iceland was 89.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Iceland?
- The highest recorded value was 91.0% in 2023.
- What is the lowest access to anti-retroviral drugs, male recorded in Iceland?
- The lowest recorded value was 27.0% in 2000.
- How does Iceland rank for access to anti-retroviral drugs, male?
- Iceland ranks 17th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Iceland?
- Over the last ten years it is up 36.9%. The long-run trend across the full record is rising.
- Where does this Iceland data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.